MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 8. Intangible Assets
At September 30, 2023 and December 31, 2022, the Company had $598.1 million and $652.5 million of intangible assets in its ATM segment and $38.5 million and $57.8 million in its FBS segment, respectively. The gross carrying amount and accumulated amortization for intangible assets consisted of the following (in millions):
| | | | | | | | | | | | | | | | | | | |
| September 30, 2023 |
| Gross Carrying Amount | | Accumulated Amortization | | | | Net Carrying Amount |
Amortized Intangible Assets |
Customer relationships | $ | 732.6 | | | $ | 194.5 | | | | | $ | 538.1 | |
Developed technology | 71.1 | | | 32.0 | | | | | 39.1 | |
Trade names | 32.7 | | | 6.6 | | | | | 26.1 | |
Acquired technology | 20.3 | | | 3.6 | | | | | 16.7 | |
Non-compete agreements | 2.9 | | | 2.8 | | | | | 0.1 | |
Patents | 1.9 | | | 0.9 | | | | | 1.0 | |
Total(1)(2) | $ | 861.5 | | | $ | 240.4 | | | | | $ | 621.1 | |
| | | | | | | |
Unamortized Intangible Assets |
Trade names | $ | 15.5 | | | $ | — | | | | | $ | 15.5 | |
(1) Includes a decrease of $26.0 million related to measurement period adjustments for the Merger recognized during the nine months ended September 30, 2023.
(2) Includes $0.7 million intangible asset impairment for the three and nine months ended September 30, 2023.
| | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| Gross Carrying Amount | | Accumulated Amortization | | | | Net Carrying Amount |
Amortized Intangible Assets |
Customer relationships | $ | 754.8 | | | $ | 159.4 | | | | | $ | 595.4 | |
Developed technology | 71.2 | | | 26.5 | | | | | 44.7 | |
Trade names | 35.8 | | | 4.4 | | | | | 31.4 | |
Acquired technology | 23.5 | | | 1.6 | | | | | 21.9 | |
Non-compete agreements | 2.9 | | | 2.7 | | | | | 0.2 | |
Patents | 1.9 | | | 0.7 | | | | | 1.2 | |
Total | $ | 890.1 | | | $ | 195.3 | | | | | $ | 694.8 | |
| | | | | | | |
Unamortized Intangible Assets |
Trade names(1) | $ | 15.5 | | | $ | — | | | | | $ | 15.5 | |
(1) During the first quarter of 2022, indefinite-lived trade names and developed technology with net carrying amounts of $4.2 million and $0.5 million were allocated to the disposal group classified as held for sale and subsequently impaired.
Amortization expense of intangible assets was $15.5 million and $14.8 million for the three months ended September 30, 2023 and 2022, respectively, and $45.5 million and $37.0 million for the nine months ended September 30, 2023 and 2022, respectively. Finite-lived intangibles are expensed using the straight-line amortization method.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 9. Restructuring and Other Impairment Activities
The Company incurred restructuring and other impairment expense of $16.3 million and $1.8 million for the three months ended September 30, 2023 and 2022, respectively, and $17.6 million and $17.3 million for the nine months ended September 30, 2023 and 2022, respectively.
Restructuring and other impairment expenses in the ATM segment were $6.8 million for the three months ended September 30, 2023. During the third quarter of 2023, we announced plans to close two facilities as a result of decisions to exit certain end markets amid ongoing manufacturing optimization efforts. The facilities are expected to close in 2024 and 2025. As a result of these planned closures, $5.5 million of fixed asset and certain other asset impairment was recognized.
In addition, the ATM segment recognized $0.5 million of restructuring expense for the three months ended September 30, 2023 related to facilities closed in prior years.
Restructuring and other impairment expenses in the ATM segment for the three months ended September 30, 2022 were $0.9 million, which included $0.7 million related to facilities closed in prior years.
In the ATM segment, restructuring and other impairment expenses for the nine months ended September 30, 2023 were $8.0 million primarily comprised of fixed asset and certain other asset impairment for our planned facility closures and $1.5 million related to facilities closed in prior years. Restructuring and other impairment expenses for the nine months ended September 30, 2022 were $14.9 million, primarily related to the impairment of certain assets in conjunction with the divestiture of a portion of the legacy SWM ATM segment. These assets were sold during the third quarter of 2022 for net proceeds of $4.6 million and a loss of $0.4 million.
Through September 30, 2023 the Company has recognized accumulated restructuring charges of $5.5 million related to the announced facility closures and $2.7 million related to facilities closed in prior years in the ATM segment. During the remainder of 2023, the Company expects to record additional restructuring related costs in the ATM segment of approximately $3.1 million related to the closing of these facilities.
In the FBS segment, restructuring and other impairment expenses for the nine months ended September 30, 2023 and 2022 were $9.6 million and $1.6 million, respectively. During the third quarter of 2023 the Company recognized impairment charges of $9.5 million related to long-lived assets at our Eerbeek, Netherlands facility. An impairment assessment was performed after significant changes in market conditions, including the entrance of new competitors and products caused management to revise our long-term view on pricing and volume recovery. The impairment reduced the carrying value of the assets to fair value, which was determined using management estimates for future cash flows. Restructuring and other impairment expenses for the nine months ended September 30, 2022 were $1.6 million related to closed facilities.
Other restructuring related inventory adjustments and acceleration of depreciation due to changes in the estimated lives of certain assets resulting from planned facility closures are included in Cost of products sold. We recorded $2.8 million and $3.1 million for the three and nine months ended September 30, 2023 primarily to write down inventory to estimated net realizable value. There were no other restructuring related inventory adjustments for the three and nine months ended September 30, 2022.
Other restructuring related charges are included in corporate General expense as other unallocated items as these costs are not included in management's evaluation of the segments' performance. There were no unallocated expenses included in corporate General expense in the three months ended September 30, 2023 and $1.1 million in the nine months ended September 30, 2023 related to the relocation of the corporate headquarters. Unallocated restructuring and other impairment expense for the three and nine months ended September 30, 2022 included $0.8 million related to the modification of leases resulting from the Merger.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The following table summarizes total restructuring, restructuring related, and other impairment expense (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
| 2023 | | 2022 | | 2023 | | 2022 |
Restructuring and other impairment expense: | | | | | | | |
Severance | $ | — | | | $ | 0.3 | | | $ | 0.1 | | | $ | 1.5 | |
Asset impairment | 15.0 | | | 0.8 | | | 15.0 | | | 13.7 | |
Other | 1.3 | | | 0.7 | | | 2.5 | | | 2.1 | |
Total restructuring and other impairment expense | $ | 16.3 | | | $ | 1.8 | | | $ | 17.6 | | | $ | 17.3 | |
Other restructuring related charges - Cost of products sold | | | | | | | |
Accelerated depreciation and amortization | $ | — | | | $ | — | | | $ | 0.3 | | | $ | — | |
Inventory write-downs to estimated net realizable value | $ | 2.8 | | | $ | — | | | $ | 2.8 | | | — | |
Total other restructuring related charges - Cost of products sold | 2.8 | | | — | | | 3.1 | | | — | |
Other restructuring related charges - General expense | | | | | | | |
Accelerated depreciation and amortization | — | | | — | | | 1.1 | | | — | |
Total restructuring, restructuring related and other impairment expense | $ | 19.1 | | | $ | 1.8 | | | $ | 21.8 | | | $ | 17.3 | |
The following table summarizes changes in restructuring liabilities (in millions):
| | | | | | | | | | | | |
| | Nine Months Ended September 30, |
| | 2023 | | 2022 |
Balance at beginning of period | | $ | 4.0 | | | $ | 3.8 | |
Accruals for announced programs | | (0.2) | | | 0.3 | |
Accruals assumed from Merger(1) | | — | | | 2.3 | |
Cash payments | | (0.5) | | | (1.5) | |
Foreign exchange impact | | — | | | (0.1) | |
Balance at end of period | | $ | 3.3 | | | $ | 4.8 | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
(1) Accrued liabilities primarily for severance related to an optimization program at facilities acquired through the Merger.
Restructuring liabilities were classified within Accrued expenses and other current liabilities and Other liabilities in the unaudited Condensed Consolidated Balance Sheets.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 10. Debt
Total debt, net of debt issuance costs, is summarized in the following table (in millions):
| | | | | | | | | | | |
| September 30, 2023 | | December 31, 2022 |
Revolving facility - U.S. dollar borrowings | $ | 266.0 | | | $ | 191.0 | |
Term loan A facility | 190.5 | | | 192.0 | |
Term loan B facility | 342.1 | | | 344.8 | |
Delayed draw term loan | 617.5 | | | 641.9 | |
6.875% Senior unsecured notes due October 1, 2026, net of discount of $3.5 million and $4.3 million at September 30, 2023 and December 31, 2022, respectively(1) | 338.5 | | | 339.0 | |
| | | |
German loan agreement | 9.9 | | | 10.7 | |
| | | |
Debt issuance costs | (26.0) | | | (29.4) | |
Total debt | 1,738.5 | | | 1,690.0 | |
Less: Current debt | (34.5) | | | (33.6) | |
Total long-term debt | $ | 1,704.0 | | | $ | 1,656.4 | |
(1) Amount includes a $8.0 million and $6.7 million decrease in fair value as of September 30, 2023 and December 31, 2022, respectively, due to changes in benchmark interest rates related to the senior unsecured notes. Refer to Note 11. Derivatives for additional information on our interest rate swaps designated as a fair value hedge.
Credit Facility
On September 25, 2018, the Company entered into a $700.0 million credit agreement (the “Credit Agreement”), which replaced the Company’s previous senior secured credit facilities and provides for a five-year $500.0 million revolving line of credit (the “Revolving Credit Facility”) and a seven-year $200.0 million bank term loan facility (the “Term Loan A Facility”). Subject to certain conditions, including the absence of a default or event of default under the Credit Agreement, the Company may request incremental loans to be extended under the Revolving Credit Facility or as additional Term Loan Facilities so long as the Company is in pro forma compliance with the financial covenants set forth in the Credit Agreement and the aggregate of such increases does not exceed $400.0 million.
On February 10, 2021, the Company amended its Credit Agreement to, among other things, add a new seven-year $350.0 million Term Loan B Facility (the “Term Loan B Facility”) and to decrease the incremental loans that may be extended at the Company’s request to $250.0 million. The amended Credit Agreement was further amended effective February 22, 2022 to adjust the step-down schedule for the maximum net debt to EBITDA ratio.
On May 6, 2022, the Company further amended its Credit Agreement in order to extend the maturity of the Revolving Credit Facility and the Term Loan A Facility to May 6, 2027, and to increase the availability under the Revolving Credit Facility, subject to consummation of the Merger, to $600.0 million. Additionally, the Company added a $650.0 million delayed draw term loan facility (the "Delayed Draw Term Loan Facility"), which the Company borrowed on July 5, 2022, in connection with the Merger. The Delayed Draw Term Loan Facility matures on May 6, 2027.
Effective July 1, 2023, pursuant to the amended Credit Agreement on June 5, 2023, borrowings under the Term Loan B Facility in U.S. dollar will bear interest equal to a forward-looking term rate based on Term SOFR (subject to a minimum floor of 0.75%) plus 2.75%. Borrowings under the Term Loan B Facility in Euros will bear interest equal to EURIBOR (subject to a minimum floor of 0%) plus 3.75%.
On September 29, 2023, the Company further amended its Credit Agreement to permit the consummation of the sale of the Company's Engineered Papers business to the buyer. Under the terms of the Amended Credit Agreement, Mativ will continue to be required to maintain certain financial ratios and comply with certain financial covenants consistent with the Prior Agreement, including a requirement to maintain a maximum net debt to EBITDA ratio of
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(a) 4.75 to 1.00 for the consecutive trailing four fiscal quarter period ended September 30, 2023, (b) (i) solely if the Transaction has not been consummated on or before December 31, 2023, 4.75 to 1.00, or (ii) otherwise, 4.50 to 1.00, for such period ended December 31, 2023, and (c) 4.50 to 1.00 for such period ended March 31, 2024 and thereafter.
Borrowings under the amended Term Loan A Facility ("Term Loan A Credit Facility") will bear interest, at a rate equal to either (1) a forward-looking term rate based on the Secured Overnight Financing Rate (“Term SOFR”), plus the applicable margin or (2) the highest of (a) the federal funds effective rate plus 0.5%, (b) the rate of interest as published by the Wall Street Journal as the “bank prime loan” rate, and (c) Term SOFR plus 1.0%, in each case plus the applicable margin. The applicable margin for borrowings under the Term Loan A Credit Facility is expected to range from 1.25% to 2.75% for SOFR loans and from 0.25% to 1.75% for base rate loans, in each case depending on the Company’s then current net debt to EBITDA ratio.
Borrowings under the amended Revolving Facility or the Delayed Draw Term Loan facility in U.S. dollars will bear interest, at the Company’s option, at a rate equal to either (1) a forward-looking term rate based on Term SOFR, plus the applicable margin or (2) the highest of (a) the federal funds effective rate plus 0.5%, (b) the rate of interest as published by the Wall Street Journal as the “bank prime loan” rate, and (c) one-month Term SOFR plus 1.0%, in each case plus the applicable margin. Borrowings under the Revolving Facility in Euros will bear interest at a rate equal to the reserve-adjusted Euro interbank offered rate, or EURIBOR, plus the applicable margin. The applicable margin for borrowings under the revolving credit agreement is expected to range from 1.00% to 2.50% for SOFR loans and EURIBOR loans, and from 0.00% to 1.50% for base rate loans, in each case, depending on the Company’s then current net debt to EBITDA ratio.
Borrowings under the Term Loan B Facility will bear interest, at the Company's option, at either (i) 3.75% in excess of a reserve adjusted LIBOR rate (subject to a minimum floor of 0.75%) or (ii) 2.75% in excess of an alternative base rate.
Under the terms of the amended Credit Agreement, the Company is required to maintain certain financial ratios and comply with certain financial covenants, including maintaining a net debt to EBITDA ratio, as defined in the amended Credit Agreement, calculated on a trailing four fiscal quarter basis, not greater than 4.75x and an interest coverage ratio, also as defined in the amended Credit Agreement, of not less than 3.00x. The maximum allowable net debt to EBITDA ratio will decrease returning to 4.50x no later than March 31, 2024, as defined in the amendment entered on September 29, 2023. In addition, borrowings and loans made under the amended Credit Agreement are secured by substantially all of the Company’s and the guarantors’ personal property, excluding certain customary items of collateral, and will be guaranteed by the Company’s existing and future wholly-owned direct material domestic subsidiaries and by SWM Luxembourg.
The Company was in compliance with all of its covenants under the amended Credit Agreement at September 30, 2023.
Indenture for 6.875% Senior Unsecured Notes Due 2026
On September 25, 2018, the Company closed a private offering of $350.0 million of 6.875% senior unsecured notes due 2026 (the “Notes”). The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended, pursuant to a purchase agreement between the Company, certain subsidiaries of the Company and a third-party financial institution, as representative of the initial purchasers. The Notes are guaranteed on a senior unsecured basis by each of the Company’s existing and future wholly-owned subsidiaries that is a borrower under or that guarantees obligations under the amended Credit Agreement or that guarantees certain other indebtedness, subject to certain exceptions.
The Notes were issued pursuant to an Indenture, dated as of September 25, 2018 (the “Indenture”), by and among the Company, the guarantors listed therein and a third-party financial institution, as trustee. The Indenture provides that interest on the Notes will accrue from September 25, 2018 and is payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2019, and the Notes mature on October 1, 2026.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The Company may redeem some or all of the Notes at any time on or after October 1, 2021, at the redemption prices set forth in the Indenture, together with accrued and unpaid interest, if any, to, but excluding, the redemption date. If the Company sells certain assets or consummates certain change of control transactions, the Company will be required to make an offer to repurchase the Notes, subject to certain conditions.
The Indenture contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to incur additional indebtedness, make certain dividends, repurchase Company stock or make other distributions, make certain investments, create liens, transfer or sell assets, merge or consolidate and enter into transactions with the Company’s affiliates. Such covenants are subject to a number of exceptions and qualifications set forth in the Indenture. The Indenture also contains certain customary events of default, including failure to make payments in respect of the principal amount of the Notes, failure to make payments of interest on the Notes when due and payable, failure to comply with certain covenants and agreements and certain events of bankruptcy or insolvency. The Company was in compliance with all of its covenants under the Indenture at September 30, 2023.
Other
On May 30, 2022, Neenah entered into a project financing agreement for the construction of a melt blown machine (the "German Loan Agreement"). This debt was assumed by the Company upon consummation of the Merger. The German Loan Agreement provided $10.7 million of construction financing which is secured by the melt blown machine. The loan matures in March 2027 and principal is repaid in equal quarterly installments beginning in June 2023. The interest rate on amounts outstanding is 1.75% and is payable quarterly.
As of September 30, 2023, the average interest rate was 8.25% on outstanding Revolving Facility borrowings, 8.17% on outstanding Term Loan A Credit Facility borrowings, 9.18% on outstanding Term Loan B Facility borrowings, and 7.92% on outstanding Delayed Draw Term Loan Facility borrowings. The effective rate on the 6.875% senior unsecured notes due 2026 was 7.248%. The weighted average effective interest rate on the Company's debt facilities, including the impact of interest rate hedges, was approximately 5.97% and 4.90% for the nine months ended September 30, 2023 and 2022, respectively.
Principal Repayments
The following is the expected maturities for the Company's debt obligations as of September 30, 2023 (in millions):
| | | | | |
2023 | $ | 10.8 | |
2024 | 40.6 | |
2025 | 40.6 | |
2026 | 379.2 | |
2027 | 966.0 | |
Thereafter | 327.3 | |
Total | $ | 1,764.5 | |
Fair Value of Debt
At September 30, 2023 and December 31, 2022, the fair market value of the Company's 6.875% senior unsecured notes was $319.4 million and $308.4 million, respectively. The fair market value for the senior unsecured notes was determined using quoted market prices, which are directly observable Level 1 inputs. The fair market value of all other debt as of September 30, 2023 and December 31, 2022 approximated the respective carrying amounts as the interest rates approximate current market indices.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 11. Derivatives
In the normal course of business, the Company is exposed to foreign currency exchange rate risk and interest rate risk on its variable-rate debt. To manage these risks, the Company utilizes a variety of practices including, where considered appropriate, derivative instruments. The Company has no derivative instruments for trading or speculative purposes or derivatives with credit risk-related contingent features. All derivative instruments used by the Company are either exchange traded or are entered into with major financial institutions to reduce credit risk and risk of nonperformance by third parties. The fair values of the Company’s derivative instruments are determined using observable inputs and are considered Level 2 assets or liabilities.
The Company utilizes currency forward, swap and, to a lesser extent, option contracts to selectively hedge its exposure to foreign currency risk when it is practical and economical to do so. The use of these contracts minimizes transactional exposure to exchange rate changes. We designate certain of our foreign currency hedges as cash flow hedges. Changes in the fair value of cash flow hedges are reported as a component of Accumulated other comprehensive loss, net of tax and reclassified into earnings when the forecasted transaction affects earnings. For foreign exchange contracts not designated as cash flow hedges, changes in the contracts’ fair values are recorded to Net income (loss) each period.
The Company selectively hedges its exposure to interest rate increases on variable-rate, long-term debt when it is practical and economical to do so. Changes in the fair value of interest rate contracts considered cash flow hedges are reported as a component of Accumulated other comprehensive loss, net of tax and reclassified into earnings when the forecasted transaction affects earnings. Interest rate contracts are also used to hedge changes in the fair value of a portion of our senior unsecured notes attributable to changes in the benchmark interest rate. Changes in the fair value of the interest rate contracts and corresponding portion of the hedged debt are recognized in Interest expense.
The Company also uses cross-currency swap contracts to selectively hedge its exposure to foreign currency related changes in our net investments in certain foreign operations. We designate these cross-currency swap contracts as net investment hedges. Changes in the fair value of these hedges are deferred within the foreign currency translation component of Accumulated other comprehensive loss, net of tax and reclassified into earnings when the foreign investment is sold or substantially liquidated.
During the second quarter of 2022, the Company entered into cross-currency swaps, with a combined notional value of €450.0 million ($478.2 million) maturing on April 1, 2024 and 2025 and October 1, 2026, designated as a hedge of a portion of the Company’s net investment in Euro-denominated subsidiaries. These contracts involve the periodic exchange of U.S. dollar fixed interest rate payments for fixed Euro-denominated payments over the respective contract terms, in addition to an exchange of notional amounts upon maturity. One cross-currency swap involves the periodic exchange of U.S. dollar variable interest rate payments for Euro-denominated variable payments.
During 2019 and 2021, the Company entered into a series of pay-fixed, receive-variable interest rate swaps, maturing on January 31, 2027 and December 31, 2027. During March 2022, the interest rate swaps, which had a combined notional value of $500.0 million were terminated and a total settlement of $23.6 million was received from the counterparties. The settlement amount, which represents the fair value of contracts at the time of termination, was recorded in Accumulated other comprehensive loss, net of tax and will be amortized as a component of Interest expense over the remaining term of the hedged forecasted transaction.
During March 2022, immediately following the termination of the aforementioned interest rate swaps, the Company entered into pay-fixed, receive-variable interest rate swaps, maturing on January 31, 2027 and December 31, 2027. The swaps have a combined notional value of $500.0 million which declines over the terms of the underlying contracts. The terms of the interest rate swaps mirror the terms of the underlying debt, including timing of the payments and interest rates.
During June 2022, the Company entered into a fixed to float interest rate swap with a notional amount of $173.4 million, maturing on October 1, 2026. The swap was designated as a fair value hedge for a portion of our
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
6.875% senior unsecured notes due in 2026. The contract involves the periodic exchange of fixed interest rate payments for variable payments.
During September 2022, the Company entered into pay-fixed, receive-variable interest rate swaps, maturing on May 6, 2027 and April 20, 2028. The swaps have a combined notional value of $650.0 million which declines over the terms of the underlying contracts. The terms of the interest rate swaps mirror the terms of the underlying debt, including timing of the payments and interest rates.
The following table presents the fair value of asset and liability derivatives and the respective balance sheet locations at September 30, 2023 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Asset Derivatives | | Liability Derivatives |
| Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value |
Derivatives designated as hedges: | | | | | | | |
Foreign exchange contracts - net investment hedge | Accounts receivable, net | | $ | 2.9 | | | Accrued expenses and other current liabilities | | $ | 0.2 | |
Foreign exchange contracts - net investment hedge | Other assets | | 3.6 | | | Other liabilities | | 2.8 | |
Interest rate contracts - cash flow hedge | Accounts receivable, net | | 0.4 | | | Accrued expenses and other current liabilities | | — | |
Interest rate contracts - cash flow hedge | Other assets | | 48.8 | | | Other liabilities | | — | |
Interest rate contracts - fair value hedge | Other assets | | — | | | Other liabilities | | 8.0 | |
Total derivatives designated as hedges | | | $ | 55.7 | | | | | $ | 11.0 | |
| | | | | | | |
Derivatives not designated as hedges: | | | | | | | |
Foreign exchange contracts | Accounts receivable, net | | 1.2 | | | Accrued expenses and other current liabilities | | 1.0 | |
Total derivatives not designated as hedges | | | $ | 1.2 | | | | | $ | 1.0 | |
Total derivatives | | | $ | 56.9 | | | | | $ | 12.0 | |
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The following table presents the fair value of asset and liability derivatives and the respective balance sheet locations at December 31, 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Asset Derivatives | | Liability Derivatives |
| Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value |
Derivatives designated as hedges: | | | | | | | |
Foreign exchange contracts - net investment hedge | Accounts receivable, net | | $ | 2.4 | | | Accrued expenses and other current liabilities | | $ | 0.2 | |
Foreign exchange contracts - net investment hedge | Other assets | | 1.1 | | | Other liabilities | | 4.7 | |
Interest rate contracts - cash flow hedge | Accounts receivable, net | | 0.6 | | | Accrued expenses and other current liabilities | | — | |
Interest rate contracts - cash flow hedge | Other assets | | 38.1 | | | Other liabilities | | — | |
Interest rate contracts - fair value hedge | Other assets | | — | | | Other liabilities | | 6.7 | |
Total derivatives designated as hedges | | | $ | 42.2 | | | | | $ | 11.6 | |
| | | | | | | |
Derivatives not designated as hedges: | | | | | | | |
Foreign exchange contracts | Accounts receivable, net | | 2.7 | | | Accrued expenses and other current liabilities | | 2.1 | |
Total derivatives not designated as hedges | | | $ | 2.7 | | | | | $ | 2.1 | |
Total derivatives | | | $ | 44.9 | | | | | $ | 13.7 | |
The following table presents the fair value of fixed-to-floating interest rate swaps designated as a fair value hedge of our Notes and the respective balance sheet location at September 30, 2023 (in millions):
| | | | | | | | | | | | | | | | | |
| Balance Sheet Location | | Carrying Amount of Hedged Item | | Cumulative Amount of Adjustment Included in Carrying Amount |
Interest rate contracts - fair value hedge | Long-term debt | | $ | 338.5 | | | $ | (8.0) | |
Refer to Note 10. Debt for further information on the Notes.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The following table provides the net effect that derivative instruments designated in hedging relationships had on Accumulated other comprehensive loss, net of tax and results of operations (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives Designated in Hedging Relationships | | Unrealized Gain (Loss) Recognized in AOCL on Derivatives, Net of Tax | | Location of Gain (Loss) Reclassified from AOCL | | Gain (Loss) Reclassified from AOCL |
| | Three Months Ended September 30, | | Nine Months Ended September 30, | | | | Three Months Ended September 30, | | Nine Months Ended September 30, |
| | 2023 | | 2022 | | 2023 | | 2022 | | | | 2023 | | 2022 | | 2023 | | 2022 |
Derivatives designated as cash flow hedge | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Foreign exchange contracts | | $ | — | | | $ | 0.1 | | | $ | 0.2 | | | $ | 0.3 | | | Other income,(expense) net | | $ | — | | | $ | — | | | $ | 0.1 | | | $ | (0.1) | |
Interest rate contracts | | (2.8) | | | 19.7 | | | (15.5) | | | 47.8 | | | Interest expense | | (6.9) | | | (3.0) | | | (19.5) | | | (4.5) | |
Derivatives designated as net investment hedge | | | | | | | | | | | | | | | | | | |
Foreign exchange contracts | | 11.2 | | | 0.1 | | | 2.9 | | | 43.7 | | | | | | | | | | | |
Total gain (loss) | | $ | 8.4 | | | $ | 19.9 | | | $ | (12.4) | | | $ | 91.8 | | | | | $ | (6.9) | | | $ | (3.0) | | | $ | (19.4) | | | $ | (4.6) | |
The Company's designated derivative instruments are highly effective. As such, there were no gains or losses recognized immediately in income related to the hedge ineffectiveness or amounts excluded from hedge effectiveness testing for the three and nine months ended September 30, 2023 and 2022, other than those related to the cross-currency swaps, noted below.
The Company’s net investment hedges were designated with terms based on the spot rate of the EUR. Future changes in the components related to the spot change on the notional will be recorded as a component of Accumulated other comprehensive loss, net of tax until the hedged subsidiaries are substantially liquidated. All coupon payments are recorded in earnings and the initial value of excluded components currently recorded in Accumulated other comprehensive loss, net of tax as an unrealized translation adjustment are amortized to Interest expense over the remaining term of the swap. For the three months ended September 30, 2023 and 2022, the Company recognized as income $3.4 million and $2.1 million, respectively, in Interest expense as derivative amounts excluded from effectiveness testing. For the nine months ended September 30, 2023 and 2022, the Company recognized as income $8.0 million and $6.9 million, respectively, in Interest expense as derivative amounts excluded from effectiveness testing.
The following table provides the effect the derivative instruments not designated as cash flow hedging instruments had on Net income (loss) (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives Not Designated as Cash Flow Hedging Instruments | | Location of Gain (Loss) Recognized | | Amount of Gain (Loss) Recognized |
| | | | Three Months Ended September 30, | | Nine Months Ended September 30, |
| | | | 2023 | | 2022 | | 2023 | | 2022 |
Foreign exchange contracts | | Other income (expense), net | | $ | (5.1) | | | $ | 0.3 | | | $ | (6.2) | | | $ | (0.2) | |
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 12. Commitments and Contingencies
Litigation
Brazil
SWM-Brazil ("SWM-B") received assessments from the tax authorities of the State of Rio de Janeiro (the "State") for unpaid Imposto sobre Circulação de Mercadorias e Serviços ("ICMS") and Fundo Estadual de Combate à Pobreza ("FECP") value-added taxes on interstate purchases of electricity. The State issued four sets of assessments against SWM-B for periods from May 2006 through December 2017 (collectively the "Electricity Assessments"). The first through fourth assessments were received in February 2008, June 2011, October 2013, and August 2018, respectively.
SWM-B challenged all Electricity Assessments in administrative proceedings before the State tax council (in the Junta de Revisão Fiscal “first-level administrative court” and the Conselho de Contribuintes “administrative appellate court”) based on Resolution 1.610/89, which defers these taxes on electricity purchased by an "electricity-intensive consumer." In 2014, a majority of the administrative appellate court sitting en banc ruled against SWM-B in each of the first and second Electricity Assessments ($11.9 million based on the foreign currency exchange rate at September 30, 2023), and SWM-B is now pursuing challenges to these assessments in the State judicial system where SWM-B obtained preliminary injunctions against enforcement of both assessments. In March 2020, the first-level judicial court ruled in favor of SWM-B in the second Electricity Assessment, a decision that is now on appeal. The third Electricity Assessment was dismissed on technical grounds in 2018. In August 2018, the State filed revised fourth Electricity Assessments for a combined amount of $9.9 million. SWM-B filed challenges to these 2018 assessments in the first-level administrative court on the same grounds as the older cases, receiving unfavorable rulings from the courts in 2019. Both 2019 decisions are being appealed. The State issued a new regulation effective January 1, 2018 that only specific industries are “electricity-intensive consumers,” a list that excludes paper manufacturers. SWM-B contends this regulation shows that paper manufacturers were electricity-intensive consumers eligible to defer ICMS before 2018. As SWM-B cannot determine the outcome of the Electricity Assessments matters, no loss has been accrued in our unaudited condensed consolidated financial statements.
Germany
In January 2015, the Company initiated patent infringement proceedings in Germany against Glatz under multiple low ignition propensity ("LIP") related patents. In December 2017, the Dusseldorf Appeal Court affirmed the German District Court judgment on infringement of EP1482815 against Glatz. The Company filed an action against Glatz in the German District Court to set the amount of damages for the infringement and Glatz filed a counterclaim. Glatz filed an action in the German Patent Court to invalidate the German part of EP1482815. The German Patent Court held that some of the patent claims at issue were invalid and also that another claim at issue was valid. The Company appealed the portion of the decision with respect to the claims held to be invalid. The German Supreme Court held that the claims of German counterpart of EP1482815 relevant to the Glatz infringement action were invalid. This ruling has the effect of nullifying the infringement decision and injunction against Glatz and the Company’s claim for damages against Glatz. Glatz’s counterclaim against the Company was settled in June 2023. The Company recognized a $4.9 million loss during the three months ended June 30, 2023, which was included in Other income (expense), net in the unaudited Condensed Consolidated Statements of Income (Loss). The settlement was paid in the three months ended September 30, 2023.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Environmental Matters
The Company's operations are subject to various nations' federal, state and local laws, regulations and ordinances relating to environmental matters. The nature of the Company's operations exposes it to the risk of claims with respect to various environmental matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims. While the Company has incurred in the past several years, and will continue to incur, capital and operating expenditures in order to comply with environmental laws and regulations, it believes that its future cost of compliance with environmental laws, regulations and ordinances, and its exposure to liability for environmental claims and its obligation to participate in the remediation and monitoring of certain hazardous waste disposal sites, will not have a material effect on its financial condition or results of operations. However, future events, such as changes in existing laws and regulations, or unknown contamination or costs of remediation of sites owned, operated or used for waste disposal by the Company (including contamination caused by prior owners and operators of such sites or other waste generators) may give rise to additional costs which could have a material effect on its financial condition or results of operations.
Employees and Labor Relations
As of September 30, 2023, approximately 24% of the Company's U.S. workforce and 28% of its Non-U.S. workforce are under collective bargaining agreements. Approximately 0% of all U.S. employees and 9% of Non-U.S. employees are under collective bargaining agreements that will expire in the next 12 months.
For the Non-U.S. workforce, union membership is voluntary and does not need to be disclosed to the Company under local laws. As a result, the number of employees covered by the collective bargaining agreements in some countries cannot be determined.
General Matters
In the ordinary course of conducting business activities, the Company and its subsidiaries become involved in certain other judicial, administrative and regulatory proceedings involving both private parties and governmental authorities. These proceedings include insured and uninsured regulatory, employment, intellectual property, general and commercial liability, environmental and other matters. At this time, the Company does not expect any of these proceedings to have a material effect on its reputation, business, financial condition, results of operations or cash flows. However, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, financial condition, results of operations or cash flows.
Note 13. Postretirement and Other Benefits
The Company sponsors a number of different defined contribution retirement plans, alternative retirement plans and/or defined benefit pension plans across its operations. Defined benefit pension plans are sponsored in the United States, France, United Kingdom, Germany, Italy, Netherlands, and Canada and OPEB benefits related to post-employment healthcare and life insurance are sponsored in the United States, Germany, and Canada.
In connection with the Merger, the Company assumed Neenah's defined benefit pension and OPEB plans, as well as sponsorship of the defined contribution retirement plan. In addition, Neenah has a supplemental employee retirement plan ("SERP"), which is a non-qualified defined benefit plan, and a supplemental retirement contribution plan ("SRCP"), which is a non-qualified, unfunded defined contribution plan. The Company provides benefits under the non-qualified SERP and SRCP plans to the extent necessary to fulfill the intent of its retirement plans without regard to the limitations set by the Internal Revenue Code on qualified retirement benefit plans.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Pension and Other Benefits
The components of net pension cost (benefit) were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Other Post-employment Plans(1) |
| U.S. | | Non-U.S. | | U.S. | | Non-U.S. |
| Three Months Ended September 30, |
| 2023 | | 2022 | | 2023 | | 2022 | | 2023 |
Service cost | $ | 0.4 | | | $ | 0.5 | | | $ | 0.3 | | | $ | 0.2 | | | $ | — | | | $ | 0.3 | |
Interest cost | 4.4 | | | 4.1 | | | 2.1 | | | 1.4 | | | 0.3 | | | — | |
Expected return on plan assets | (5.5) | | | (5.0) | | | (1.1) | | | (1.2) | | | — | | | — | |
| | | | | | | | | | | |
Amortizations and other | — | | | 0.5 | | | 0.1 | | | — | | | — | | | — | |
Net pension cost (benefit) | $ | (0.7) | | | $ | 0.1 | | | $ | 1.4 | | | $ | 0.4 | | | $ | 0.3 | | | $ | 0.3 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pension Benefits | | Other Post-employment Plans(1) | | | | | |
| U.S. | | Non-U.S. | | U.S. | | Non-U.S. | | | |
| Nine Months Ended September 30, |
| 2023 | | 2022 | | 2023 | | 2022 | | 2023 | | | | | |
Service cost | $ | 1.2 | | | $ | 0.5 | | | $ | 0.8 | | | $ | 0.4 | | | $ | 0.1 | | | $ | 0.9 | | | | | | |
Interest cost | 13.3 | | | 5.7 | | | 6.3 | | | 3.0 | | | 0.9 | | | 0.1 | | | | | | |
Expected return on plan assets | (16.6) | | | (7.0) | | | (3.3) | | | (3.1) | | | — | | | — | | | | | | |
| | | | | | | | | | | | | | | | |
Amortizations and other | — | | | 1.3 | | | 0.4 | | | — | | | — | | | — | | | | | | |
Net pension cost (benefit) | $ | (2.1) | | | $ | 0.5 | | | $ | 4.2 | | | $ | 0.3 | | | $ | 1.0 | | | $ | 1.0 | | | | | | |
(1) As of September 30, 2022, the Company's U.S. and Non-U.S. OPEB liabilities were immaterial and therefore not included in these disclosures.
The components of net pension cost (benefit) other than the service cost component are included in Other income (expense), net in the unaudited Condensed Consolidated Statements of Loss.
The Company's cost under the qualified defined contribution retirement plans was $3.2 million and $3.6 million, respectively, for the three months ended September 30, 2023 and 2022 and $10.9 million and $8.3 million, respectively, for the nine months ended September 30, 2023 and 2022.
Note 14. Income Taxes
For interim financial reporting, the Company estimates the annual tax rate based on projected taxable income for the full year and records a quarterly income tax provision in accordance with ASC 740-270, Accounting for Income Taxes in Interim Periods. These interim estimates are subject to variation due to several factors, including the ability of the Company to accurately forecast pre-tax and taxable income and loss by jurisdiction, changes in laws or regulations, and expenses or losses for which tax benefits are not recognized. Jurisdictions with a projected loss for the year or an actual year-to-date loss where no tax benefit can be recognized are excluded from the estimated annual effective tax rate. The impact of including these jurisdictions on the quarterly effective tax rate calculations could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings versus annual projections.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Prior to the passage of the Tax Cuts and Jobs Act of 2017 ("Tax Act"), the Company asserted that substantially all of the undistributed earnings of its foreign subsidiaries were considered indefinitely reinvested and accordingly, no deferred taxes were provided. Due to the Tax Act, the Company has significant previously taxed earnings and profits from its foreign subsidiaries, as a result of transition tax, that is generally able to be repatriated free of U. S. federal tax. In addition, future earnings of foreign subsidiaries are generally expected to be able to be repatriated free of U.S. federal income tax because these earnings were taxed in the U.S. under the GILTI regime or would be eligible for a 100% dividends received deduction. As a result of the Company’s treasury policy to simplify and expediate its intercompany cash flows, as evidenced by the use of cash pooling, and in light of the Company’s demonstrated goal of driving growth though inorganic/acquisitional means, the Company does not assert indefinite reinvestment to the extent of each controlled foreign corporation's earnings and profits and to the extent of any foreign partnership’s U.S. tax capital accounts. As a result, the Company has provided for non-U.S. withholding taxes, U.S. federal tax related to currency movement on previously taxed earnings and profits, and U.S. state taxes on unremitted earnings.
All unrecognized tax positions could impact the Company's effective tax rate if recognized. There have been no material changes to the Company’s unrecognized tax positions for the three and nine months ended September 30, 2023. With respect to penalties and interest incurred from income tax assessments or related to unrecognized tax benefits, the Company’s policy is to classify penalties as provision for income taxes and interest as interest expense in its unaudited Condensed Consolidated Statements of Loss. There were no material income tax penalties or interest accrued during the three and nine months ended September 30, 2023 or 2022.
The Company's effective tax rate from continuing operations was (6.2)% and 24.6% for the three months ended September 30, 2023 and 2022, respectively. The net change was primarily due to a $32.0 million valuation allowance expense in the current period. The Company's effective tax rate from continuing operations was (6.5)% and 17.8% for the nine months ended September 30, 2023 and 2022, respectively. The net change was primarily due to a $40.0 million valuation allowance expense in the current period.
Note 15. Segment Information
Prior to the completion of the Merger, we operated in two reportable segments: Advanced Materials & Structures and Engineered Papers. Effective with the Merger, the Company reassessed its reportable segments. Management concluded that it had two operating product line segments that are also the reportable segments for financial reporting purposes: Advanced Technical Materials and Fiber-Based Solutions. ATM was comprised of the legacy SWM Advanced Materials & Structures segment and certain legacy Neenah segments allocated to ATM based on performance, market focus, technologies, and reporting structure. FBS was comprised of the legacy Neenah Fine Paper and Packaging segment and the legacy Engineered Papers segment. As such, there were no changes to the historical results of these segments. The merged Neenah segments were allocated to ATM and FBS based on performance, market focus, technologies, and reporting structure. Effective July 1, 2023, and as a result of our ongoing integration efforts, we identified a change in our operating segments to align with our end markets due to changes in segment level management and the related internal review of operating results.
The ATM reportable segment remains an aggregation of the Company's Industrials, Protective Solutions, Filtration, Healthcare, and Release Liners operating segments. ATM's end markets provide solutions that filter and purify air and liquids, supports adhesive and protective applications, advances healing and wellness, and solves some of material science’s most demanding performance needs across a number of categories. The FBS reportable segment leverages the company’s extensive natural fiber capabilities to provide specialty solutions for various end-uses, including sustainable packaging, imaging and communications, home and office, consumer goods, and other applications. As a result of the Engineered Papers Transaction, the EP business is presented as a discontinued operation and no longer reported in the FBS reportable segment. The FBS segment is now comprised of Packaging and specialty papers end markets and prior year results have been recasted to reflect such adjustments.
The accounting policies of the reportable segments are the same as those described in Note 2. Summary of Significant Accounting Policies in the notes to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Information about Net Sales and Operating Profit
The Company primarily evaluates segment performance and allocates resources based on operating profit. General corporate expenses that do not directly support the operations of the business segments are unallocated expenses. Assets are managed on a total company basis and are therefore not disclosed at the segment level.
Net sales and operating profit by segments were (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net Sales |
| |
| | | | | | | | | | | |
| Three Months Ended September 30, | | | | Nine Months Ended September 30, |
| 2023 | | | | 2022 | | | | 2023 | | 2022 |
ATM | $ | 393.8 | | | | | $ | 426.1 | | | | | $ | 1,248.0 | | | | | $ | 987.1 | | | |
FBS | 104.4 | | | | | 125.4 | | | | | 325.7 | | | | | 125.4 | | | |
Total Consolidated | $ | 498.2 | | | | | $ | 551.5 | | | | | $ | 1,573.7 | | | | | $ | 1,112.5 | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Operating Profit (Loss) |
| |
| | | | | | | | | | | |
| Three Months Ended September 30, | | | | Nine Months Ended September 30, |
| 2023 | | | | 2022 | | | | 2023 | | 2022 |
ATM | $ | (378.8) | | | | | $ | 31.5 | | | | | $ | (306.1) | | | | | $ | 71.2 | | | |
FBS | (4.4) | | | | | 10.3 | | | | | (1.1) | | | | | 9.1 | | | |
Unallocated | (36.7) | | | | | (73.4) | | | | | (104.5) | | | | | (122.6) | | | |
Total Consolidated | $ | (419.9) | | | | | $ | (31.6) | | | | | $ | (411.7) | | | | | $ | (42.3) | | | |
Note 16. Discontinued Operations
Upon entering into the Engineered Papers Offer agreement, the Engineered Papers business met the criteria set forth in Accounting Standards Codification 205-20, Presentation of Financial Statements – Discontinued Operations (“ASC 205-20”), as the sale represents a strategic shift that will have a major effect on the Company’s operations and financial results. As a result, the Company’s consolidated financial statements for all periods presented reflect the Engineered Papers business as a discontinued operation. The divested business was historically reported in the FBS reportable segment.
The Engineered Papers business was tested for recoverability as of each balance sheet date since meeting the discontinued operations criteria and the Company concluded that there is no impairment expense to be recognized.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Included within the unaudited condensed consolidated balance sheet are the following major classes of assets and liabilities, respectively, associated with the discontinued operations (in millions):
| | | | | | | | | | | |
| September 30, 2023 | | December 31, 2022 |
ASSETS | | | |
Cash and cash equivalents | $ | 19.0 | | | $ | 23.3 | |
Accounts receivable, net | 95.3 | | | 88.6 | |
Inventories, net | 118.6 | | | 120.2 | |
Income taxes receivable | 2.8 | | | 0.4 | |
| | | |
| | | |
Other current assets | 2.6 | | | 1.3 | |
| | | |
Total current assets | 238.3 | | | 233.8 | |
Property, plant and equipment, net | 177.5 | | | 183.5 | |
Finance lease right-of-use assets | 0.2 | | | — | |
Operating lease right-of-use assets | 4.6 | | | 5.2 | |
| | | |
Investment in equity affiliates | 55.8 | | | 59.1 | |
Goodwill | 3.0 | | | 3.0 | |
| | | |
Other assets | 5.5 | | | 5.3 | |
| | | |
Total assets of discontinued operations | $ | 484.9 | | | $ | 489.9 | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | |
Current debt | $ | 0.1 | | | $ | 1.1 | |
Finance lease liabilities | 0.1 | | | — | |
Operating lease liabilities | 0.7 | | | 0.8 | |
Accounts payable | 43.0 | | | 45.1 | |
Income taxes payable | 1.4 | | | 1.2 | |
| | | |
Accrued expenses and other current liabilities | 44.4 | | | 55.2 | |
| | | |
Total current liabilities | 89.7 | | | 103.4 | |
Long-term debt | 3.2 | | | 2.9 | |
Finance lease liabilities, noncurrent | 0.1 | | | — | |
Operating lease liabilities, noncurrent | 4.2 | | | 4.6 | |
Long-term income tax payable | 0.6 | | | 0.6 | |
Pension and other postretirement benefits | 20.8 | | | 21.3 | |
Deferred income tax liabilities | 16.0 | | | 20.1 | |
Other liabilities | 18.1 | | | 17.4 | |
| | | |
Total liabilities of discontinued operations | 152.7 | | | 170.3 | |
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Summary financial results of discontinued operations were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
| 2023 | | 2022 | | 2023 | | 2022 |
Net sales | $ | 127.2 | | | $ | 122.6 | | | $ | 399.1 | | | $ | 394.8 | |
Cost of products sold | 92.3 | | | 95.7 | | | 309.9 | | | 298.1 | |
Gross profit | 34.9 | | | 26.9 | | | 89.2 | | | 96.7 | |
| | | | | | | |
Selling expense | 3.7 | | | 3.3 | | | 11.0 | | | 10.5 | |
Research and development expense | 2.2 | | | 1.8 | | | 7.1 | | | 5.6 | |
General expense | 3.7 | | | 4.3 | | | 10.9 | | | 13.6 | |
Total nonmanufacturing expenses | 9.6 | | | 9.4 | | | 29.0 | | | 29.7 | |
| | | | | | | |
| | | | | | | |
Restructuring and other impairment expense | 0.5 | | | — | | | 0.6 | | | 0.2 | |
Operating income | 24.8 | | | 17.5 | | | 59.6 | | | 66.8 | |
Interest expense(1) | (12.3) | | | (8.9) | | | (35.1) | | | (15.0) | |
Other income, net | 1.4 | | | 1.3 | | | 8.3 | | | 10.0 | |
Income from discontinued operations before income taxes | 13.9 | | | 9.9 | | | 32.8 | | | 61.8 | |
Income tax expense | 4.8 | | | (0.4) | | | 6.3 | | | 9.6 | |
Income (loss) from equity affiliates, net of income taxes | 0.2 | | | 1.2 | | | 0.4 | | | 5.1 | |
Net income from discontinued operations | 9.3 | | | 11.5 | | | 26.9 | | | 57.3 | |
(1) Upon the close of the transaction, the Company plans to use a portion of the net proceeds to repay a portion of its outstanding debt amounting to approximately $575 million. This debt repayment is based on the triggering of a financial covenant in the loan agreement and interest expense has been allocated to discontinued operations on a pro-rata basis within the Condensed Consolidated Statement of Income (Loss) and the Condensed Consolidated Statement of Cash Flows based on the outstanding loan balances.
Note 17. Subsequent Events
On October 4, 2023, pursuant to the terms of the Offer Letter and following the conclusion of the French Consultation Process, the Company accepted Evergreen Hill Enterprise’s Offer and countersigned the Purchase Agreement, with respect to the Engineered Papers Transaction.
On October 20, 2023, the Company and the purchasers under the Company’s accounts receivable securitization facility entered into an amendment to the Company’s accounts receivable securitization facility (the “Amended A/R Facility”) to, among other things, facilitate the Engineered Papers Transaction. The documentation for the Amended A/R Facility included (i) Amendment No. 1 to the Receivables Purchase Agreement by and among the Company and the SPE (“Seller”), the persons from time to time party thereto as purchasers (the “Purchasers”), PNC Bank, National Association, as administrative agent (“PNC” or “Administrative Agent”), and PNC Capital Markets LLC, as structuring agent (the “Receivables Purchase Agreement Amendment”) and (ii) Amendment No. 1 to Sale and Contribution Agreement (the “Sale and Contribution Agreement Amendment”), by and among the Company, the originators party thereto, and the Seller.
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The Receivables Purchase Agreement Amendment amends the original Receivables Purchase Agreement, dated as of December 23, 2022 (as amended, the “Amended Receivables Purchase Agreement”) and the Sale and Contribution Agreement Amendment amends the original Sale and Contribution Agreement, dated as of December 23, 2022 (as amended, the “Amended Sale and Contribution Agreement”), in each case by, among other things, (i) reflecting the repurchase by the Company from Seller of all of its accounts receivable and certain related assets previously sold by Company to Seller (collectively, “Receivables”), (ii) reflecting that the Company is no longer an originator of Receivables under the Amended A/R Facility, but remains the servicer and performance guarantor, (iii) reflecting the Company’s assignment of 100% of the ownership interests in Seller to Neenah, Inc., a wholly-owned subsidiary of the Company (“Neenah”), such that Neenah will now be able to contribute Receivables to Seller on a go-forward basis pursuant to the terms of the Sale and Contribution Agreement, as so amended, and (iv) updating the maximum Net Debt to EBITDA Ratio to match the level set forth in the Company’s First Lien Credit Agreement as in effect on the date of such amendments.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a discussion of our financial condition and results of operations. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this report and the audited consolidated financial statements and related notes and the selected financial data included in our Annual Report on Form 10-K for the year ended December 31, 2022. The discussion of our financial condition and results of operations includes various forward-looking statements about our markets, the demand for our products and our future prospects. These statements are based on certain assumptions we consider reasonable. For information about risks and exposures relating to us and our business, you should read the section entitled "Risk Factors" in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022, the section entitled "Forward-Looking Statements" at the end of this Item 2 and the section entitled “Risk Factors” at Part II, Item 1A hereof. Unless the context indicates otherwise, references to "Mativ," "we," "us," "our," the "Company" or similar terms include Mativ Holdings, Inc. and our consolidated subsidiaries.
This Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of our financial statements with an understanding of our recent performance, our financial condition and our prospects.
As discussed in Note 16. Discontinued Operations to the unaudited condensed consolidated financial statements, the results from continuing operations exclude the results of our EP Business for all periods presented. All information presented within this MD&A is on a continuing operations basis.
Merger
On July 6, 2022, the Company completed its previously announced merger with Neenah, Inc. ("Neenah") under the terms of an Agreement and Plan of Merger, pursuant to which a wholly-owned subsidiary merged with and into Neenah (the "Merger"), with Neenah surviving as a direct and wholly-owned subsidiary of the Company. Refer to Note 4. Business Acquisitions in the notes to the unaudited condensed consolidated financial statements for further information related to the Merger. Refer to Note 15. Segment Information in the notes to the unaudited condensed consolidated financial statements for information on our segments after the Merger.
This MD&A discusses the financial condition and results of operations of the Company as of and for the three and nine months ended September 30, 2023, which includes Neenah.
During the three month period ending September 30, 2022, the Company became aware of a cyber attack that had been made against certain systems within the Company’s network environment. The attack temporarily affected operations and caused delays in execution of sales transactions at some locations. In addition, the Company incurred financial costs to investigate and remediate the incident, some of which are expected to be mitigated by insurance. During the incident, the attackers accessed and exfiltrated Company data, including some personally identifying information of certain Company employees. The Company believes it has contained the incident, which only affected certain systems, and it has restored operations and notified affected individuals. The Company has put in place remediation measures designed to help prevent future similar attacks, and has proactively undertaken to implement certain other enhancements to its security system.
Liquidity & Debt Overview
As of September 30, 2023, the Company had $1,738.5 million of total debt, $84.7 million of cash, and undrawn capacity on its $600.0 million revolving line of credit facility (the "Revolving Facility") of $329.1 million. Per the terms of the Company's amended credit agreement (the "Amended Credit Agreement"), net leverage was 4.2x at the end of the third quarter, versus a current maximum covenant ratio of 4.75x. The Company’s nearest debt maturity is our 6.875% senior unsecured notes which are due in 2026. Refer to "Liquidity and Capital Resources" section for additional detail.
SUMMARY
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Nine Months Ended |
| September 30, | | Percent of Net Sales | | September 30, | | Percent of Net Sales |
(in millions, except per share amounts) | 2023 | | 2022 | | 2023 | | 2022 | | 2023 | | 2022 | | 2023 | | 2022 |
Net sales | $ | 498.2 | | | $ | 551.5 | | | 100.0 | % | | 100.0 | % | | $ | 1,573.7 | | | $ | 1,112.5 | | | 100.0 | % | | 100.0 | % |
Gross profit | 86.7 | | | 96.1 | | | 17.4 | % | | 17.4 | % | | 269.9 | | | 218.6 | | | 17.2 | % | | 19.6 | % |
Restructuring & impairment expense | 16.3 | | | 1.8 | | | 3.3 | % | | 0.3 | % | | 17.6 | | | 17.3 | | | 1.1 | % | | 1.6 | % |
Operating loss | (419.9) | | | (31.6) | | | (84.3) | % | | (5.7) | % | | (411.7) | | | (42.3) | | | (26.2) | % | | (3.8) | % |
Interest expense | 16.8 | | | 14.9 | | | 3.4 | % | | 2.7 | % | | 48.8 | | | 43.7 | | | 3.1 | % | | 3.9 | % |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Net loss from continuing operations | $ | (464.3) | | | $ | (34.0) | | | (93.2) | % | | (6.2) | % | | $ | (494.1) | | | $ | (66.4) | | | (31.4) | % | | (6.0) | % |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Diluted loss per share from continuing operations | $ | (8.50) | | | $ | (0.65) | | | | | | | $ | (9.06) | | | $ | (1.74) | | | | | |
Cash provided by operations | $ | 32.3 | | | $ | (19.0) | | | | | | | $ | 37.8 | | | $ | (44.6) | | | | | |
Capital spending | $ | 7.4 | | | $ | 9.3 | | | | | | | $ | 49.4 | | | $ | 27.1 | | | | | |
RESULTS OF OPERATIONS
Comparison of the Three Months Ended September 30, 2023 and 2022
Net Sales
The following table presents net sales by segment for the three months ended September 30, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | | | |
| September 30, 2023 | | September 30, 2022 | | Change | | Percent Change |
Advanced Technical Materials | $ | 393.8 | | | $ | 426.1 | | | $ | (32.3) | | | (7.6) | % |
Fiber-Based Solutions | 104.4 | | | 125.4 | | | (21.0) | | | (16.7) | % |
Total | $ | 498.2 | | | $ | 551.5 | | | $ | (53.3) | | | (9.7) | % |
Consolidated net sales of $498.2 million during the three months ended September 30, 2023 decreased $53.3 million or 9.7%, compared to the prior-year quarter.
ATM segment net sales of $393.8 million during the three months ended September 30, 2023 decreased $32.3 million, or 7.6%, compared to the prior-year quarter. ATM sales decline reflected lower volume partly offset by higher selling price and favorable currency translation. Lower volumes across the segment reflect increased customer caution in the current uncertain economic environment, as well as impacts from seasonal slowing, particularly in Europe. Healthcare was a top performer, with double-digit growth for the quarter.
FBS segment net sales of $104.4 million during the three months ended September 30, 2023 decreased $21.0 million, or 16.7%, compared to the prior-year quarter, and are now comprised solely of Packaging and Specialty Papers. The FBS sales decline reflected lower volume compared to prior year when significant industry-wide customer inventory builds occurred. Lower demand for premium business papers and packaging, along with continued customer destocking, offset benefits from increased sales of consumer papers and higher selling prices.
Gross Profit
The following table presents gross profit for the three months ended September 30, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | | | Percent Change | | Percent of Net Sales |
| September 30, 2023 | | September 30, 2022 | | Change | | | 2023 | | 2022 |
Net sales | $ | 498.2 | | | $ | 551.5 | | | $ | (53.3) | | | (9.7) | % | | 100.0 | % | | 100.0 | % |
Cost of products sold | 411.5 | | | 455.4 | | | (43.9) | | | (9.6) | % | | 82.6 | % | | 82.6 | % |
Gross profit | $ | 86.7 | | | $ | 96.1 | | | $ | (9.4) | | | (9.8) | % | | 17.4 | % | | 17.4 | % |
Gross profit of $86.7 million during the three months ended September 30, 2023 decreased $9.4 million, or 9.8%, compared to the prior-year quarter. The decrease in gross profit reflected lower volume impacts, and associated manufacturing inefficiencies and fixed cost absorption, partly offset by benefits of selling prices net of input costs and favorable currency translation. The Company monitors and continues to adjust staffing levels of manufacturing labor relative to volumes.
Non-manufacturing Expenses
The following table presents non-manufacturing expenses for the three months ended September 30, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | | | Percent Change | | Percent of Net Sales |
| September 30, 2023 | | September 30, 2022 | | Change | | | 2023 | | 2022 |
Selling expense | $ | 20.5 | | | $ | 19.1 | | | $ | 1.4 | | | 7.3 | % | | 4.1 | % | | 3.5 | % |
Research expense | 5.4 | | | 5.9 | | | (0.5) | | | (8.5) | % | | 1.1 | % | | 1.1 | % |
General expense | 63.4 | | | 100.9 | | | (37.5) | | | (37.2) | % | | 12.8 | % | | 18.3 | % |
Non-manufacturing expenses | $ | 89.3 | | | $ | 125.9 | | | $ | (36.6) | | | (29.1) | % | | 17.9 | % | | 22.8 | % |
Non-manufacturing expenses of $89.3 million during the three months ended September 30, 2023 decreased $36.6 million, or 29.1%, compared to the prior-year quarter. The decrease is primarily due to higher costs in 2022 including direct and indirect merger acquisition and integration costs of $46.7 million, and $5.7 million to resolve the cybersecurity incident in the prior year quarter, partially offset by $17.3 million of costs related to the merger, planned divestiture of the EP business and financing fees in the current quarter.
Restructuring and Other Impairment Expense
The following table presents restructuring and other impairment expense for the three months ended September 30, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | | | | | | | Percent of Net Sales |
| September 30, 2023 | | September 30, 2022 | | Change | | | | | 2023 | | 2022 |
Advanced Technical Materials | $ | 6.8 | | | $ | 0.9 | | | $ | 5.9 | | | | | | | 0.5 | % | | 0.2 | % |
Fiber-Based Solutions | 9.5 | | | 0.1 | | | 9.4 | | | | | | | 2.9 | % | | 0.1 | % |
Unallocated expenses | — | | | 0.8 | | | (0.8) | | | | | | | | | |
Total | $ | 16.3 | | | $ | 1.8 | | | $ | 14.5 | | | | | | | 1.0 | % | | 0.3 | % |
The Company incurred total restructuring and other impairment expense of $16.3 million and $1.8 million in the three months ended September 30, 2023 and 2022, respectively. In the current year period, restructuring and other impairment expense in the ATM segment was driven by plans to close two facilities as a result of decisions to exit certain end markets, ongoing manufacturing optimization efforts and facilities closed in prior years. In the FBS segment, restructuring and impairment expense in the current year period was driven by impairment of long-lived assets, predominantly equipment at our Eerbeek, Netherlands facility.
In the prior year period, restructuring and impairment expense in the ATM segment was related to facilities closed in prior years.
Restructuring and impairment costs related to the Merger are included in corporate expenses as other unallocated items as these costs are not included in management's evaluation of the segments' performance. Unallocated restructuring expenses for the three months ended September 30, 2022 included $0.8 million related to the modification of leases resulting from the Merger.
Operating Loss
The following table presents operating profit/(loss) by segment for the three months ended September 30, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | | | Percent Change | | Return on Net Sales |
| September 30, 2023 | | September 30, 2022 | | Change | | | 2023 | | 2022 |
Advanced Technical Materials | $ | (378.8) | | | $ | 31.5 | | | $ | (410.3) | | | (1,302.5) | % | | (96.2) | % | | 7.4 | % |
Fiber-Based Solutions | (4.4) | | | 10.3 | | | (14.7) | | | (142.7) | % | | (4.2) | % | | 8.2 | % |
Unallocated expenses | (36.7) | | | (73.4) | | | 36.7 | | | (50.0) | % | | | | |
Total | $ | (419.9) | | | $ | (31.6) | | | $ | (388.3) | | | 1,228.8 | % | | (84.3) | % | | (5.7) | % |
Operating loss of $419.9 million during the three months ended September 30, 2023, increased $388.3 million, or 1,228.8%, compared to the prior year period. Both periods included unusual costs as previously described and related to an impairment charge in 2023 and the merger in 2022.
In the ATM segment, operating loss was $378.8 million during the three months ended September 30, 2023 reflecting a $410.3 million, or 1,302.5% change, compared to the prior year period primarily due to the goodwill impairment recorded of $401.0 million. For more information on the goodwill impairment, see Note 7. Goodwill. In the FBS segment, operating loss of $4.4 million during the three months ended September 30, 2023 decreased $14.7 million, or 142.7%, compared to the prior year period. In both segments, operating profit reflects lower volumes offsetting favorable impacts of net selling price/input cost increases. Unallocated expenses of $36.7 million during the three months ended September 30, 2023 decreased $36.7 million, or 50.0%, compared to the prior year period primarily due to the merger and integration related costs incurred in the prior year period.
Interest Expense
Interest expense of $16.8 million during the three months ended September 30, 2023 increased $1.9 million, or 12.8%, compared to the prior year period. Interest expense increased primarily due to higher average interest rates.
Other Income (Expense), Net
Other income (expense), net was $(0.3) million during the three months ended September 30, 2023, compared to the prior year period income of $1.4 million. The net change was primarily driven by losses on foreign exchange contracts.
Income Taxes
A $27.3 million income tax expense in the three months ended September 30, 2023 resulted in an effective tax rate of (6.2)% compared with 24.6% in the prior year period. The net change was primarily due to a $32.0 million valuation allowance expense in the current period.
Net Loss and Net Loss per Share
Net loss during the three months ended September 30, 2023 was $464.3 million, or $8.50 per diluted share, compared with net loss of $34.0 million, or $0.65 per diluted share, during the prior-year quarter.
RESULTS OF OPERATIONS
Comparison of the Nine Months Ended September 30, 2023 and 2022
Net Sales
The following table presents net sales by segment (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | | | | |
| 2023 | | 2022 | | Change | | Percent Change |
Advanced Technical Materials | $ | 1,248.0 | | | $ | 987.1 | | | $ | 260.9 | | | 26.4 | % |
Fiber-Based Solutions | 325.7 | | | 125.4 | | | 200.3 | | | 159.7 | % |
Total | $ | 1,573.7 | | | $ | 1,112.5 | | | $ | 461.2 | | | 41.5 | % |
Consolidated net sales of $1,573.7 million during the nine months ended September 30, 2023 increased $461.2 million, or 41.5%, compared to the prior year period.
ATM segment net sales of $1,248.0 million during the nine months ended September 30, 2023 increased $260.9 million, or 26.4%, compared to the prior year period. ATM sales growth was due to the addition of the Neenah operations. Price increases across the product lines, in response to higher input costs were offset by volume declines. The decreased volume was caused by customer de-stocking trends and an uncertain macro environment.
FBS segment net sales of $325.7 million during the nine months ended September 30, 2023 increased $200.3 million, or 159.7%, compared to the prior year period. FBS sales growth was due to the addition of the Neenah operations. Consistent with trends in ATM, price increases across the FBS product lines in response to higher input costs were offset by volume declines which were mostly driven by customer de-stocking in packaging and specialty paper.
Gross Profit
The following table presents gross profit (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | | | | Percent Change | | Percent of Net Sales |
| 2023 | | 2022 | | Change | | | 2023 | | 2022 |
Net sales | $ | 1,573.7 | | | $ | 1,112.5 | | | $ | 461.2 | | | 41.5 | % | | 100.0 | % | | 100.0 | % |
| | | | | | | | | | | |
Cost of products sold | 1,303.8 | | | 893.9 | | | 409.9 | | | 45.9 | % | | 82.8 | % | | 80.4 | % |
Gross profit | $ | 269.9 | | | $ | 218.6 | | | $ | 51.3 | | | 23.5 | % | | 17.2 | % | | 19.6 | % |
Gross profit of $269.9 million during the nine months ended September 30, 2023 increased $51.3 million, or 23.5%, compared to the prior year period. The increase in gross profit reflected the addition of the Neenah operations. While price increases more than offset higher input costs across both segments, lower volume impacts, along with manufacturing inefficiencies negatively impacted results. The Company addressed production performance across several facilities, primarily in FBS, which have been impacted by high manufacturing labor turnover and resulted in less efficient operations. Profitability in both segments was also impacted by staffing levels of manufacturing labor relative to volumes, and the Company has adjusted staffing levels to be in line with demand requirements.
Non-manufacturing Expenses
The following table presents non-manufacturing expenses (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | | | | Percent Change | | Percent of Net Sales |
| 2023 | | 2022 | | Change | | | 2023 | | 2022 |
Selling expense | $ | 60.6 | | | $ | 41.1 | | | $ | 19.5 | | | 47.4 | % | | 3.9 | % | | 3.7 | % |
Research and development expense | 16.6 | | | 12.7 | | | 3.9 | | | 30.7 | % | | 1.1 | % | | 1.1 | % |
General expense | 185.8 | | | 189.8 | | | (4.0) | | | (2.1) | % | | 11.8 | % | | 17.1 | % |
Non-manufacturing expenses | $ | 263.0 | | | $ | 243.6 | | | $ | 19.4 | | | 8.0 | % | | 16.8 | % | | 21.9 | % |
Non-manufacturing expenses of $263.0 million during the nine months ended September 30, 2023 increased by $19.4 million, or 8.0%, compared to the prior year period. The increase is primarily due to the addition of Neenah's non-manufacturing expenses which includes an increase in amortization expenses related to Neenah's intangible assets, partially offset by lower integration related expenses in 2023.
Restructuring and Other Impairment Expense
The following table presents restructuring and other impairment expense by segment (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | | | | | | | | Percent of Net Sales |
| 2023 | | 2022 | | Change | | | | | 2023 | | 2022 |
Advanced Technical Materials | $ | 8.0 | | | $ | 14.9 | | | $ | (6.9) | | | | | | | 0.6 | % | | 1.5 | % |
Fiber-Based Solutions | 9.6 | | | 1.6 | | | 8.0 | | | | | | | 2.9 | % | | 1.3 | % |
Unallocated expenses | — | | | 0.8 | | | (0.8) | | | | | | | | | |
Total | $ | 17.6 | | | $ | 17.3 | | | $ | 0.3 | | | | | | | 1.1 | % | | 1.6 | % |
The Company incurred total restructuring and other impairment expense of $17.6 million in the nine months ended September 30, 2023 compared with $17.3 million in the prior year period. In the current year period, restructuring and other impairment expense in the ATM segment was primarily comprised of fixed asset and certain other asset impairment for our announced planned facility closures and facilities closed in prior years. Restructuring and other impairment expense in the FBS segment was primarily driven by impairment of long-lived assets, predominantly equipment at our Eerbeek, Netherlands facility.
The Company incurred total restructuring and other impairment expense of $17.3 million in the nine months ended September 30, 2022. In the ATM segment, restructuring and impairment expense for the prior year period were primarily related to the impairment of certain assets in conjunction with the divestiture of a portion of the legacy SWM ATM segment serving the industrials end market. These assets were sold during the third quarter of 2022 for net proceeds of $4.6 million and a loss of $0.4 million. In the prior-year period restructuring and other impairment expense in the FBS segment included $1.5 million primarily related to closed facilities.
Operating Loss
The following table presents operating profit (loss) by segment (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, | | | | Percent Change | | Return on Net Sales |
| 2023 | | 2022 | | Change | | | 2023 | | 2022 |
Advanced Technical Materials | $ | (306.1) | | | $ | 71.2 | | | $ | (377.3) | | | (529.9) | % | | (24.5) | % | | 7.2 | % |
Fiber-Based Solutions | (1.1) | | | 9.1 | | | (10.2) | | | (112.1) | % | | (0.3) | % | | 7.3 | % |
Unallocated expenses | (104.5) | | | (122.6) | | | (18.1) | | | (14.8) | % | | | | |
Total | $ | (411.7) | | | $ | (42.3) | | | $ | (369.4) | | | 873.3 | % | | (26.2) | % | | (3.8) | % |
Operating loss of $411.7 million during the nine months ended September 30, 2023 increased $369.4 million, or 873.3%, compared to the prior year period.
In the ATM segment, operating loss was $306.1 million during the nine months ended September 30, 2023 reflecting a $377.3 million, or 529.9% change, compared to the prior year period operating profit primarily attributed to a goodwill impairment recorded of $401.0 million. In the FBS segment, operating loss of $1.1 million during the nine months ended September 30, 2023 decreased $10.2 million, or 112.1%, compared to the prior year period. In both segments, operating profit reflects the addition of the Neenah operations and the benefit of price increases more than offsetting higher input costs, which were offset by declining volumes across most products. The decline in FBS operating profits was largely driven by manufacturing inefficiencies at several facilities, as well as intangible asset amortization expenses associated with the Merger, and $9.5 million of costs related to the impairment of long-lived assets, predominantly equipment at our Eerbeek, Netherlands facility. Unallocated expenses of $104.5 million during the nine months ended September 30, 2023 decreased $18.1 million, or 14.8% compared to the prior year period primarily due to the merger and integration related costs incurred in the prior year period, offset by the addition of Neenah's unallocated expenses and integration and divestiture related costs in the current period.
Interest Expense
Interest expense of $48.8 million during the nine months ended September 30, 2023 increased $5.1 million, or 11.7%, compared to the prior year period. Interest expense increased primarily due to incremental debt related to the Merger, the incremental expense of assuming Neenah's debt, and higher average interest rates.
Other Income (Expense), Net
Other income (expense), net of $3.6 million during the nine months ended September 30, 2023 decreased $8.8 million, or 169.2% compared to the prior year period. The net change was primarily driven by the gain on the sale of equipment at the Winkler facility in the prior period, partially offset by legal and tax settlement expenses in the current period.
Income Taxes
A $30.0 million income tax expense in the nine months ended September 30, 2023 resulted in an effective tax rate of (6.5)% compared with 17.8% in the prior year period. The net change was primarily due to a $40.0 million valuation allowance expense in the current period.
Net Income (Loss) and Net Income (Loss) per Share
Net loss during the nine months ended September 30, 2023 was $467.2 million, or $8.57 per diluted share, compared to net income of $9.1 million, or $0.25 per diluted share, during the prior year period.
LIQUIDITY AND CAPITAL RESOURCES
A major factor in our liquidity and capital resource planning is our generation of cash flow from operations, which is sensitive to changes in the mix of products sold, volume and pricing of our products, as well as changes in our production volumes, costs and working capital. Our liquidity is supplemented by funds available under our Revolving Facility with a syndicate of banks that is used as either operating conditions or strategic opportunities warrant.
Cash Requirements
As of September 30, 2023, $59.5 million of the Company's $84.7 million of cash and cash equivalents was held by foreign subsidiaries. We believe our sources of liquidity and capital, including cash on-hand, cash generated from operations and our existing credit facilities, will be sufficient to finance our continued operations, our current and long-term growth plan, and dividend payments.
Cash Provided by (Used in) Operating Activities
Net cash provided by operating activities was $37.8 million during the nine months ended September 30, 2023 compared to net cash used of $44.6 million during the prior year period. Compared to the prior year period, cash inflows from working capital increased by $65.9 million, due to a reduction in inventories in the current period.
Working Capital
As of September 30, 2023, the Company had net working capital of $546.3 million, including cash and cash equivalents of $84.7 million, compared to net working capital of $538.5 million, including cash and cash equivalents of $101.1 million as of December 31, 2022. During the nine months ended September 30, 2023, net changes in operating working capital resulted in a cash inflow of $13.4 million, an increase from $79.3 million of outflows during the prior year period largely due to decreases in receivables and inventory.
Cash Used in Investing Activities
Cash used in investing activities during the nine months ended September 30, 2023 was $49.4 million, compared to cash outflows of $453.4 million during the prior year period, which were mainly attributable to capital spending, and reflected the addition of the Neenah operations and repayment of Neenah's outstanding debt. Within investing cash flows, capital spending was $49.4 million compared to $27.1 million in the prior year period, reflecting the addition of Neenah operations and capacity expansion projects for filtration and release liner products. Investing cash flows in the prior year period also included $35.8 million inflow from cash received in the settlement of cross-currency swaps contracts.
Cash Provided by (Used in) Financing Activities
Cash used in financing activities during the nine months ended September 30, 2023 was $13.2 million, compared to cash provided of $461.5 million during the prior year period. During the nine months ended September 30, 2023, financing activities primarily consisted of $180.0 million of borrowings under the revolving credit facility, $49.8 million of dividends paid to the Company's stockholders, and payments on our long-term debt of $134.2 million.
During the prior year period, financing activities primarily consisted of $179.5 million of payments on our long-term debt, $720.4 million of proceeds from borrowings under the revolving credit facility, the proceeds of which were primarily used to repay Neenah's debt upon consummation of the Merger, $50.1 million in cash paid for dividends paid to the Company's stockholders, and $22.6 million of payments for debt issuance costs associated with the amendment of our Credit Agreement as discussed in Note 10. Debt of the notes to the unaudited condensed consolidated financial statements.
The Company presently believes the sources of liquidity discussed above are sufficient to meet our anticipated funding needs for the foreseeable future.
Dividends and Share Repurchases
On November 8, 2023, we announced a cash dividend of $0.10 per share payable on December 15, 2023 to stockholders of record as of November 24, 2023. The covenants contained in our Indenture and amended Credit Agreement require that we maintain certain financial ratios as disclosed in Note 10. Debt of the notes to the unaudited condensed consolidated financial statements, none of which under normal business conditions materially limit our ability to pay such dividends. We will continue to assess our dividend policy in light of our overall strategy, cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.
During the nine months ended September 30, 2023, the company repurchased $7.0 million of outstanding shares of which $4.4 million were repurchased as part of the share buyback program authorized by the Board of Directors in August 2023. The Company intends to repurchase shares periodically and opportunistically to offset dilution due to stock compensation. During the quarter ended September 30, 2022, the company repurchased $6.4 million of outstanding shares.
Debt Instruments and Related Covenants
The following table presents activity related to our debt instruments for the nine months ended September 30, 2023 and 2022 (in millions):
| | | | | | | | | | | |
| |
| | |
| Nine Months Ended September 30, |
2023 | | 2022 |
Proceeds from long-term debt | $ | 180.0 | | | $ | 720.4 | |
Payments on long-term debt | (134.2) | | | (179.5) | |
| | | |
Net proceeds from borrowings | $ | 45.8 | | | $ | 540.9 | |
Net proceeds from borrowings were $45.8 million during the nine months ended September 30, 2023, compared to net repayments of $540.9 million during the prior year period.
On June 5, 2023, the Company amended its Credit Agreement to replace LIBOR-based rates with term-SOFR for the Term Loan B Facility. Effective July 1, 2023, borrowings under the Term Loan B Facility in U.S. dollar will bear interest equal to a forward-looking term rate based on Term SOFR (subject to a minimum floor of 0.75%) plus 2.75%. Borrowings under the Term Loan B Facility in Euros will bear interest equal to EURIBOR (subject to a minimum floor of 0.00%) plus 3.75%.
Unused borrowing capacity under the amended Credit Agreement was $329.1 million as of September 30, 2023.
The Company was in compliance with all of its covenants under the Indenture and amended Credit Agreement at September 30, 2023. With the current level of borrowing and forecasted results, we expect to remain in compliance with financial covenants under the amended Credit Agreement.
Our total debt to capital ratios, as calculated under the amended Credit Agreement, at September 30, 2023 and December 31, 2022 were 72.1% and 58.9%, respectively.
Critical Accounting Policies and Estimates
The preparation of our unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make judgments, assumptions and estimates that affect the amounts reported. There have been no material changes in our critical accounting policies and estimates since December 31, 2022 other than the below item related to goodwill.
Effective July 1, 2023, and as a result of our ongoing integration efforts, we identified a change in our operating segments. While the ATM reportable segment remains as an aggregation of the Company’s highly engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwoven products, the segment was disaggregated into five reporting units due to changes in segment level management and the related internal reporting of operating results (refer to Note 15. Segment Information for additional information on our segments).
Further, during 2023, the sustained impact of macro-economic conditions, an increasingly global competitive environment, moderation in certain projected volume expectations, and a sustained decrease in our share price contributed to the decline in reporting unit fair value. Additionally, management completed a long term financial model, aligning with the new reporting unit structure during the third quarter. That plan’s forecast reflects the higher relative allocation of corporate overhead costs to continuing operations as a result of the proposed sale of our EP business.
The fair value of a reporting unit is based on an income approach, utilizing estimated future cash flows discounted at a rate commensurate with the risk involved and considers significant assumptions including projections of future performance, specifically our ability to sustain and grow market share at forecasted margins and significant assumptions around the rate a market participant would use to discount those cash flows. Changes in these assumptions can have a significant impact on the assessment of fair value. While the fair value of each reporting unit was ultimately estimated using the income approach, management also evaluated fair value under the market approach to evaluate the reasonableness of the estimated fair values.
For further information about our critical accounting policies, please see the discussion of critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2022 in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates.”
Off-Balance Sheet Arrangements
As of September 30, 2023, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.
FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the incurrence of additional debt and expected maturities of the Company’s debt obligations, the adequacy of our sources of liquidity and capital, acquisition integration and growth prospects (including international growth), the cost and timing of our restructuring actions, the impact of ongoing litigation matters and environmental claims, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, impacts and timing of our ongoing operational excellence and other cost-reduction and cost-optimization initiatives, any lingering impact of the COVID-19 pandemic on our operations, profitability, and cash flow, the expected benefits and accretion of the Neenah merger and Scapa acquisition and integration and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.
These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this report. These risks include, among other things, those set forth in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2022, the Risk Factors set forth in the section entitled "Risk Factors" at Part II - Item 1A hereof, as well as the following factors:
•Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
•Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of Mativ, including the pending Engineered Papers Transaction;
•Adverse changes in the filtration, release liners, protective solutions, industrials and healthcare sectors impacting key ATM segment customers;
•Changes in the source and intensity of competition in our commercial end-markets: filtration, protective solutions, release liners, healthcare, and industrials for ATM, and packaging and specialty papers for FBS;
•Adverse changes in sales or production volumes, pricing and/or manufacturing costs in our ATM or FBS operating segments;
•Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
•Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
•Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
•Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
•Business disruptions from the Merger that will harm the Company's business, including current plans and operations;
•The possibility that Mativ may be unable to successfully integrate Neenah's operations with those of Mativ and achieve expected synergies and operating efficiencies within the expected time-frames or at all;
•Potential adverse reactions or changes to business relationships resulting from the Merger, including as it relates to the Company's ability to successfully renew existing client contracts on favorable terms or at all and obtain new clients;
•Our ability to attract and retain key personnel, including as a result of the Merger, labor shortages, labor strikes, stoppages or other disruptions;
•The substantial indebtedness Mativ has incurred and assumed in connection with the Merger and the need to generate sufficient cash flows to service and repay such debt;
•Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro and Real) and on interest rates;
•A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
•Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
•Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities;
•Uncertainty as to the long-term value of the common stock of Mativ, including the dilution caused by Mativ’s issuance of additional shares of its common stock in connection with the Merger;
•Changes in employment, wage and hour laws and regulations in the U.S., France and elsewhere, including the loi de Securisation de l'emploi in France, unionization rules and regulations by the National Labor Relations Board in the U.S., equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
•The impact of tariffs, and the imposition of any future additional tariffs and other trade barriers, and the effects of retaliatory trade measures;
•Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
•Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
•International conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, which restrict our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;
•Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
•The continued evolution of COVID-19, or new public health crises that may arise in the future, could have adverse and disparate impacts on the Company, our employees and customers;
•The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs, including those in Brazil, France and Germany;
•Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, particularly our sales of combustible products business within the tobacco industry, as well as our ability to achieve our broader ESG goals and objectives;
•Costs and timing of implementation of any upgrades or changes to our information technology systems;
•Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
•The impact of cybersecurity risks related to breaches of security pertaining to sensitive Company, customer, or vendor information, as well as breaches in the technology that manages operations and other business processes; and
•Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.
All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Our market risk exposure at September 30, 2023 is consistent with, and not materially different than, the market risk and discussion of exposure presented under the caption “Quantitative and Qualitative Disclosures about Market Risk” in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We currently have in place systems relating to disclosure controls and procedures designed to ensure the timely recording, processing, summarizing and reporting of information required to be disclosed in periodic reports under the Securities Exchange Act of 1934, as amended. These disclosure controls and procedures include those designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions about required disclosure. Upon completing our review and evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2023, our Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures were effective as of September 30, 2023.
Changes in Internal Control Over Financial Reporting
No changes in our internal control over financial reporting were identified as having occurred in the fiscal quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.